Chemoprevention in barrett's esophagus

Sumera Ilyas, Cathrine J. Demars, Navtej Singh Buttar

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Barrett's metaplasia-associated esophageal adenocarcinoma is one of the most rapidly increasing cancers in Western countries. Whereas early detection remains the cornerstone of prevention, chemoprevention is emerging as a complementary strategy. Carcinogenesis in Barrett's mucosa is a multistep process in which cellular growth becomes progressively dysregulated. Fortunately, the process of carcinogenesis is a protracted one, which provides ample opportunity for intervention. In this review, we will discuss various potential chemoprevention targets and rationale behind their use to prevent Barrett's related esophageal adenocarcinoma. We will also critically appraise the emerging preclinical and clinical literature regarding prevention of neoplasia in Barrett's esophagus.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalJournal of Gastrointestinal Cancer
Volume38
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Barrett Esophagus
Chemoprevention
Carcinogenesis
Adenocarcinoma
Neoplasms
Mucous Membrane
Growth

Keywords

  • Adenocarcinoma of esophagus
  • Barrett's esophagus
  • Carcinogenesis
  • Chemoprevention
  • Signaling

ASJC Scopus subject areas

  • Gastroenterology
  • Oncology

Cite this

Chemoprevention in barrett's esophagus. / Ilyas, Sumera; Demars, Cathrine J.; Buttar, Navtej Singh.

In: Journal of Gastrointestinal Cancer, Vol. 38, No. 1, 01.2007, p. 1-9.

Research output: Contribution to journalArticle

Ilyas, Sumera ; Demars, Cathrine J. ; Buttar, Navtej Singh. / Chemoprevention in barrett's esophagus. In: Journal of Gastrointestinal Cancer. 2007 ; Vol. 38, No. 1. pp. 1-9.
@article{7b2cd4ad9dfe460f91596c92692fb935,
title = "Chemoprevention in barrett's esophagus",
abstract = "Barrett's metaplasia-associated esophageal adenocarcinoma is one of the most rapidly increasing cancers in Western countries. Whereas early detection remains the cornerstone of prevention, chemoprevention is emerging as a complementary strategy. Carcinogenesis in Barrett's mucosa is a multistep process in which cellular growth becomes progressively dysregulated. Fortunately, the process of carcinogenesis is a protracted one, which provides ample opportunity for intervention. In this review, we will discuss various potential chemoprevention targets and rationale behind their use to prevent Barrett's related esophageal adenocarcinoma. We will also critically appraise the emerging preclinical and clinical literature regarding prevention of neoplasia in Barrett's esophagus.",
keywords = "Adenocarcinoma of esophagus, Barrett's esophagus, Carcinogenesis, Chemoprevention, Signaling",
author = "Sumera Ilyas and Demars, {Cathrine J.} and Buttar, {Navtej Singh}",
year = "2007",
month = "1",
doi = "10.1007/s12029-007-9006-7",
language = "English (US)",
volume = "38",
pages = "1--9",
journal = "Journal of Gastrointestinal Cancer",
issn = "1941-6628",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Chemoprevention in barrett's esophagus

AU - Ilyas, Sumera

AU - Demars, Cathrine J.

AU - Buttar, Navtej Singh

PY - 2007/1

Y1 - 2007/1

N2 - Barrett's metaplasia-associated esophageal adenocarcinoma is one of the most rapidly increasing cancers in Western countries. Whereas early detection remains the cornerstone of prevention, chemoprevention is emerging as a complementary strategy. Carcinogenesis in Barrett's mucosa is a multistep process in which cellular growth becomes progressively dysregulated. Fortunately, the process of carcinogenesis is a protracted one, which provides ample opportunity for intervention. In this review, we will discuss various potential chemoprevention targets and rationale behind their use to prevent Barrett's related esophageal adenocarcinoma. We will also critically appraise the emerging preclinical and clinical literature regarding prevention of neoplasia in Barrett's esophagus.

AB - Barrett's metaplasia-associated esophageal adenocarcinoma is one of the most rapidly increasing cancers in Western countries. Whereas early detection remains the cornerstone of prevention, chemoprevention is emerging as a complementary strategy. Carcinogenesis in Barrett's mucosa is a multistep process in which cellular growth becomes progressively dysregulated. Fortunately, the process of carcinogenesis is a protracted one, which provides ample opportunity for intervention. In this review, we will discuss various potential chemoprevention targets and rationale behind their use to prevent Barrett's related esophageal adenocarcinoma. We will also critically appraise the emerging preclinical and clinical literature regarding prevention of neoplasia in Barrett's esophagus.

KW - Adenocarcinoma of esophagus

KW - Barrett's esophagus

KW - Carcinogenesis

KW - Chemoprevention

KW - Signaling

UR - http://www.scopus.com/inward/record.url?scp=59149087661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59149087661&partnerID=8YFLogxK

U2 - 10.1007/s12029-007-9006-7

DO - 10.1007/s12029-007-9006-7

M3 - Article

VL - 38

SP - 1

EP - 9

JO - Journal of Gastrointestinal Cancer

JF - Journal of Gastrointestinal Cancer

SN - 1941-6628

IS - 1

ER -